Researchers at the University of Geneva, together with colleagues in Switzerland, France, the United States and Israel, ...
These are the famous deaths where official explanations exist — but doubt never really disappeared. Matthew Perry’s death in ...
NUZ-001, an investigational oral therapy for ALS, is officially the ninth compound to be included in the HEALEY ALS platform ...
At first, the idea of horses and wheelchair users might sound like an unlikely combination. Yet, with the Hayday with Horses ...
With the condition having far fewer treatment options than adult Parkinson’s disease, Irai’s parents were desperate. Through ...
Japan’s MHLW grants Pioneering Regenerative Medical Product designation to BlueRock Therapeutics’ investigative cell therapy, bemdaneprocel for treating Parkinson’s disease ...
Qalsody is one step closer to being covered by public Canadian healthcare systems when used to treat adults with ALS with ...
The International Society for the Advancement of Spine Surgery issued coverage recommendation for Mainstay Medical’s ReActiv8 neurostimulation, the medtech company said Dec. 11. ISASS’ statement ...
Matt Kidd, the first patient in a University of Washington safety trial, can now perform daily tasks thanks to a device that ...
The approval was supported by data from phase 3 STEER study, which enrolled patients with SMA who were treatment-naive and able to sit but never able to walk independently.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback